Mucodin Dosage & Drug Information

Concise Prescribing Info

Contents

Carbocisteine

Indications/Uses

Adjuvant therapy for patients w/ abnormal, viscid or inspissated mucous secretions in conditions eg chronic/acute broncho-pulmonary disease, pulmonary complications associated w/ surgery & cystic fibrosis, tracheostomy care, post-traumatic chest conditions, atelectasis due to mucous obstruction & diagnostic bronchial studies.

Dosage/Direction for Use

Initially 750 mg tds, then 375 mg qds. Childn 5-12 250 mg tds, <5 yr 62.5-125 mg qds.

Administration

Should be taken with food.

Special Precautions

History of peptic ulcer. Active ulceration.

Adverse Reactions

Nausea, headache, gastric discomfort, diarrhoea, GI bleeding & skin rash.

View ADR Monitoring Form

MIMS Class

Cough & Cold Preparations

ATC Classification

R05CB03 - carbocisteine ; Belongs to the class of mucolytics. Used in the treatment of wet cough.

Regulatory Classification

Presentation/Packing

Form

Mucodin syr 250 mg/5 mL

Packing/Price

120 mL x 1's;3.8 L x 1's

Mucodin

carbocisteine

Manufacturer:

Sunward

Distributor:

Apex Pharma Marketing